Treatment.Com International, Inc. (TSE:TRUE) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Treatment.com AI, a healthcare technology firm enhancing patient care with AI, has appointed seasoned executive Richard Atkins as its new Chief Operating Officer. Atkins, with over three decades of experience in health-tech, software, and international sales, is expected to significantly boost the company’s expansion efforts with his global expertise. The company has also incentivized Atkins with 250,000 stock options, underlining their confidence in his ability to advance their aggressive commercialization phase.
For further insights into TSE:TRUE stock, check out TipRanks’ Stock Analysis page.
